Ian Rossman, MD, PhD

Ian Rossman, MD, PhD

Pediatric Neurologist


NeuroDevelopmental Science Center


Neurology - Akron

Clinical Interests

Pediatric neuroinflammatory diseases, leukodystrophies, neuromuscular disease.

Medical School

Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ


Pediatrics: Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ
Pediatric Neurology: Cleveland Clinic, Cleveland OH


Neuroimmunology (Multiple Sclerosis): Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH

Board Certifications

American Board of Psychiatry and Neurology with Specialization in Child Neurology


American Academy of Neurology
Child Neurology Society
International Pediatric Multiple Sclerosis Study Group
National Multiple Sclerosis Society

Clinical Interests

Pediatric neuroinflammatory diseases, leukodystrophies, neuromuscular disease.

Research Interests

Pediatric neuroinflammatory diseases, clinical trials


Rossman, I & E. Cheng-Ching, Child Neurology, Chapter TBD, Comprehensive Review in Clinical Neurology, 2nd Edition, Book authors: E. Cheng-Ching, L. Chahine, E Baron, A. Rae-Grant, in press. Lippincott Williams & Wilkins, Philadelphia, PA.

Rossman, I. Neurogenetics, Chapter 2, Ultimate Review for the Neurology Boards, 3rd Edition. Editors: Seby John, John Morren, Alexander Rae-Grant. ISBN 13: 9781620700815. Demos Medical Publishing, New York, NY. 8JUN2016.

Rossman, I and J.A. Cohen (2016) Expert Review: Should MRI be the primary endpoint of phase 3 trials in multiple sclerosis? Expert Review of Clinical Immunology. 12(5): 489-91.

Rossman, I, and J.A. Cohen (2015) Switching sides-fingolimod versus injectable MS therapies. Nature Reviews Neurology. doi:10.1038/nrneurol.2015.59. Published online 21APR2015.

Rossman, I, and J.A. Cohen (2014) Cell-based Therapeutic Strategies in Multiple Sclerosis. European Neurological Review, 2014;9(1):37–43.

Rossman IT, Lin L, Morgan KM, Digiovine M, Van Buskirk EK, Kamdar S, Millonig JH, Dicicco-Bloom E. (2014) Engrailed2 modulates cerebellar granule neuron precursor proliferation, differentiation and insulin-like growth factor 1 signaling during postnatal development. Molecular Autism. 5(1):9. doi: 10.1186/2040-2392-5-9.

Rossman, I, and J.C. Cohen, Classic Paper Review: Rivers, Sprunt & Berry, 1933http://www.msdiscovery.org/papers/classic-papers

Rossman, I., and E. DiCicco-Bloom, “ENGRAILED2 and Cerebellar Development in the Pathogenesis of Autism Spectrum Disorders”, Autism: Current Theories and Evidence Series: Current Clinical Neurology. Zimmerman, Andrew (Ed.), Humana Press, Springer International, New York; 1st Edition, November 9, 2010

Bookmark and Share

Video and Audio View all videos and audio related to Ian Rossman, MD, PhD >>

find a location
Find a location Type the first 3-5 letters of a specialty, service or location:
Or, view: a map, a list of all locations, locations by city or locations near me.
find a doctor
Find a doctor Type the first 3-5 letters of the name, location or specialty:
Or, view a list of all doctors by name, location and specialty.